or Try an Advanced Search...

    Technical Analysis for AXLA - Axcella Health Inc.

    Grade Last Price % Change Price Change
    B 10.57 52.97% 3.66
    AXLA closed up 52.97 percent on Thursday, September 28, 2023, on 5.1 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical AXLA trend table...
    Date Alert Name Type % Chg
    Bullish Engulfing Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    New Uptrend Bullish 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Multiple of Ten Bullish Other 0.00%
    Strong but Oversold Other 0.00%
    Wide Bands Range Expansion 0.00%
    Older End-of-Day Signals for AXLA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    60 Minute Opening Range Breakout about 13 hours ago
    10x Volume Pace about 13 hours ago
    Up 1 ATR about 13 hours ago
    200 DMA Resistance about 13 hours ago
    10 DMA Resistance about 13 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AXLA Chart by TradingView
    Basic chart:

    Profile

    Axcella is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella’s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella’s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Bank Biotechnology Metabolism Cac 40 Complex Diseases

    Is AXLA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 5 bullish, 0 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 20 Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
    Sep 15 Are Medical Stocks Lagging Axcella Health (AXLA) This Year?
    Sep 14 Axcella approves 1-for-25 reverse stock split
    Sep 14 Axcella Announces Reverse Stock Split Effective September 19, 2023
    Aug 30 Are Medical Stocks Lagging Clover Health Investments (CLOV) This Year?
    Aug 30 Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug
    Aug 30 What's Going On With Axcella Health Stock This Week?
    Aug 29 US Stocks Mostly Flat; Best Buy Posts Upbeat Results
    Aug 29 Axcella Granted Patent for Long COVID Fatigue Treatment
    Aug 23 Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    See more AXLA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 48.5
    52 Week Low 2.61
    Average Volume 1,159,248
    200-Day Moving Average 10.25
    50-Day Moving Average 8.48
    20-Day Moving Average 14.15
    10-Day Moving Average 10.73
    Average True Range 4.73
    RSI (14) 41.18
    ADX 39.06
    +DI 36.94
    -DI 26.24
    Chandelier Exit (Long, 3 ATRs) 27.05
    Chandelier Exit (Short, 3 ATRs) 19.47
    Upper Bollinger Bands 28.35
    Lower Bollinger Band -0.05
    Percent B (%b) 0.37
    BandWidth 200.72
    MACD Line 0.00
    MACD Signal Line 1.38
    MACD Histogram -1.3752
    Fundamentals Value
    Market Cap 396.81 Million
    Num Shares 37.5 Million
    EPS -6.04
    Price-to-Earnings (P/E) Ratio -1.75
    Price-to-Sales 0.00
    Price-to-Book 2.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.23
    Resistance 3 (R3) 18.88 15.65 17.78
    Resistance 2 (R2) 15.65 13.45 15.82 17.30
    Resistance 1 (R1) 13.11 12.08 14.38 13.46 16.82
    Pivot Point 9.88 9.88 10.52 10.05 9.88
    Support 1 (S1) 7.34 7.68 8.61 7.69 4.32
    Support 2 (S2) 4.11 6.31 4.28 3.84
    Support 3 (S3) 1.57 4.11 3.36
    Support 4 (S4) 1.92